Identification and characterization of a novel ergothioneine conjugate of raloxifene.

IF 4.4 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Abhijith Rao, Sivaprasad Putluru, Prasanth Eapen, Hemantha Kumar, Raviraj Landge, Khemraj Bairwa, Srikanth Sridhar, T Thanga Mariappan, Michael Sinz, Prakash Vachaspati
{"title":"Identification and characterization of a novel ergothioneine conjugate of raloxifene.","authors":"Abhijith Rao, Sivaprasad Putluru, Prasanth Eapen, Hemantha Kumar, Raviraj Landge, Khemraj Bairwa, Srikanth Sridhar, T Thanga Mariappan, Michael Sinz, Prakash Vachaspati","doi":"10.1016/j.dmd.2024.100034","DOIUrl":null,"url":null,"abstract":"<p><p>Raloxifene (RX) in the presence of liver microsomes and glutathione (GSH) has shown oxidative bioactivation to reactive intermediates that are conjugated by GSH. L-Ergothioneine (ET) is a naturally occurring sulfhydryl amino acid, similar to GSH, derived from dietary sources with antioxidant properties and reported to accumulate in high concentrations in animals and humans. We hypothesized that ET may have detoxification/conjugation properties similar to GSH. Using rat and human liver microsomes and mouse, rat, dog, monkey, and human hepatocytes, a novel ergothioneine conjugate of raloxifene (RX-ET) (M1) was identified by mass spectrometry. The RX-ET conjugate was further scaled up in rat liver microsomes, isolated, and characterized by high-resolution mass spectrometry and NMR to confirm the structure. A single RX-ET conjugate was characterized and the site of ET conjugation was identified at the C-17 position of RX. The in vivo relevance of this unique conjugate was also established through metabolism studies in intact and bile duct cannulated rats, both untreated and pretreated with ET. In general, the RX-ET conjugate was found in trace amounts in plasma and urine, but in higher concentrations in bile and feces. The major elimination pathway of RX-ET was through biliary elimination. In rats that were pretreated with ET prior to RX administration, significantly larger quantities of ET and RX-ET conjugate were found in in vivo samples. Lastly, these studies suggest that ET conjugation is an additional pathway for scavenging reactive species arising from xenobiotics and may potentially reduce drug-related toxicities. SIGNIFICANCE STATEMENT: Ergothioneine is well known for its antioxidant and free radical scavenging activity. This study identifies its role in conjugating the reactive species arising from the bioactivation of raloxifene in vitro and in vivo suggesting that ergothioneine may act as an additional conjugation pathway similar to glutathione in the disposition of reactive centers or metabolites of xenobiotics.</p>","PeriodicalId":11309,"journal":{"name":"Drug Metabolism and Disposition","volume":"53 2","pages":"100034"},"PeriodicalIF":4.4000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Metabolism and Disposition","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.dmd.2024.100034","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Raloxifene (RX) in the presence of liver microsomes and glutathione (GSH) has shown oxidative bioactivation to reactive intermediates that are conjugated by GSH. L-Ergothioneine (ET) is a naturally occurring sulfhydryl amino acid, similar to GSH, derived from dietary sources with antioxidant properties and reported to accumulate in high concentrations in animals and humans. We hypothesized that ET may have detoxification/conjugation properties similar to GSH. Using rat and human liver microsomes and mouse, rat, dog, monkey, and human hepatocytes, a novel ergothioneine conjugate of raloxifene (RX-ET) (M1) was identified by mass spectrometry. The RX-ET conjugate was further scaled up in rat liver microsomes, isolated, and characterized by high-resolution mass spectrometry and NMR to confirm the structure. A single RX-ET conjugate was characterized and the site of ET conjugation was identified at the C-17 position of RX. The in vivo relevance of this unique conjugate was also established through metabolism studies in intact and bile duct cannulated rats, both untreated and pretreated with ET. In general, the RX-ET conjugate was found in trace amounts in plasma and urine, but in higher concentrations in bile and feces. The major elimination pathway of RX-ET was through biliary elimination. In rats that were pretreated with ET prior to RX administration, significantly larger quantities of ET and RX-ET conjugate were found in in vivo samples. Lastly, these studies suggest that ET conjugation is an additional pathway for scavenging reactive species arising from xenobiotics and may potentially reduce drug-related toxicities. SIGNIFICANCE STATEMENT: Ergothioneine is well known for its antioxidant and free radical scavenging activity. This study identifies its role in conjugating the reactive species arising from the bioactivation of raloxifene in vitro and in vivo suggesting that ergothioneine may act as an additional conjugation pathway similar to glutathione in the disposition of reactive centers or metabolites of xenobiotics.

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.50
自引率
12.80%
发文量
128
审稿时长
3 months
期刊介绍: An important reference for all pharmacology and toxicology departments, DMD is also a valuable resource for medicinal chemists involved in drug design and biochemists with an interest in drug metabolism, expression of drug metabolizing enzymes, and regulation of drug metabolizing enzyme gene expression. Articles provide experimental results from in vitro and in vivo systems that bring you significant and original information on metabolism and disposition of endogenous and exogenous compounds, including pharmacologic agents and environmental chemicals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信